Closed
8.73 -3.11
24h
Min
8.63
Max
8.95
Income | -2.8M -16M |
---|---|
Sales | 1.9M 19M |
EPS | -0.05 |
Profit margin | -82.793 |
Employees | 97 |
EBITDA | 1.1M -7.6M |
Recommendations | Buy |
---|---|
12 Months Forecast | +36.7% upside |
Next Earnings | 12 May 2025 |
---|
Market Cap | 3.4M 456M |
---|---|
Previous open | 11.84 |
Previous close | 8.73 |
By Trading Central
Confidence
Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 12.33 USD 36.7%
High 15 USD
Low 10 USD
Based on 3 Wall Street analysts offering 12 month price targets forTheravance Biopharma Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$